OTC "feedback" meeting
This article was originally published in The Rose Sheet
Executive Summary
Warner-Lambert scheduled to meet with FDA to discuss the regulatory pathway for producing a product that combines the anticaries and oral health monographs. The meeting will be held Oct. 8 at 10:00 a.m. in Rockville, Md. W-L presented a proposed testing protocol for a Listerine antiplaque/antigingivitis toothpaste before FDA's Dental Plaque Subcommittee last year (1"The Rose Sheet" June 1, 1998, p. 1)